Lv62
3000 积分 2023-06-12 加入
Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity
10天前
已完结
Safety, tolerability, pharmacokinetics and pharmacodynamics of GZR4, a novel once‐weekly basal insulin, in healthy participants: A randomized trial
18天前
已完结
Safety, tolerability, pharmacokinetics and pharmacodynamics of GZR4, a novel once‐weekly basal insulin, in healthy participants: A randomized trial
18天前
已完结
肠促胰素类减重药物临床应用专家共识（2025版）
27天前
已完结
Switching to once-weekly insulin icodec versus once-daily insulin degludec in individuals with basal insulin-treated type 2 diabetes (ONWARDS 2): a phase 3a, randomised, open label, multicentre, treat-to-target trial
1个月前
已完结
Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial
1个月前
已完结
Tirzepatide versus insulin glargine as second-line or third-line therapy in type 2 diabetes in the Asia-Pacific region: the SURPASS-AP-Combo trial
1个月前
已完结
Tirzepatide versus insulin glargine as second-line or third-line therapy in type 2 diabetes in the Asia-Pacific region: the SURPASS-AP-Combo trial
1个月前
已完结
Once-weekly dulaglutide versus bedtime insulin glargine, both in combination with prandial insulin lispro, in patients with type 2 diabetes (AWARD-4): a randomised, open-label, phase 3, non-inferiority study
1个月前
已完结
Macro-microporous zeolitic imidazole framework-8/cellulose aerogel for semi-automated pipette tip solid phase extraction of fluoroquinolones in water
2年前
已驳回
Macro-microporous zeolitic imidazole framework-8/cellulose aerogel for semi-automated pipette tip solid phase extraction of fluoroquinolones in water
2年前
已驳回
皖公网安备34019202002308
